Quantcast

Latest autoimmune diseases Stories

2014-06-19 04:21:28

DIEPENBEEK, Belgium, June 19, 2014 /PRNewswire/ -- Initiates Preclinical Development of Peptide Therapy Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease. Apitope, through its innovative discovery platform, has selected three peptides...

2014-06-18 08:28:52

RALEIGH, N.C., June 18, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis of metabolic disease, will present a peer-reviewed poster relating to its highly selective sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate (a prodrug of active remogliflozin), at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine...

2014-06-18 08:28:40

~Expert panel shares tips, encouraging patients to take a 360° approach to managing their disease and to not give up until they're satisfied~

2014-06-17 23:16:13

Natural Lupus Treatment System is developed by Gary M Levin, who claims to teach people how to treat their lupus quickly and naturally. An overview on the website Vinaf.com shows if the program is worth buying. Tampa, FL (PRWEB) June 17, 2014 Natural Lupus Treatment System is the latest program that provides people natural remedies, techniques, tips, and detailed instructions on how treat their lupus. In the program, people will discover all important information about lupus such as...

2014-06-17 23:07:06

There is no correlation between the consumption of a cow’s milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA). Atlanta, Georgia (PRWEB) June 17, 2014 There is no correlation between the consumption of a cow’s milk-based formula or hydrolyzed protein formula and the development of...

2014-06-16 13:03:46

University of Melbourne New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne-lead study successfully mapped the genes of a parasitic worm in pigs New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne – lead study successfully mapped the genes of a...

2014-06-16 12:29:02

DEERFIELD, Ill., and OSAKA, Japan, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the United States (U.S.) commercial availability of a new biologic therapy, ENTYVIO((TM) )(vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD). "We understand how a great need still exists for additional treatment options...

2014-06-12 12:30:07

Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass., June 12, 2014 /PRNewswire/ -- Decision Resources Group finds that, within one year of commercial availability, 100 percent of surveyed U.S. neurologists have prescribed Biogen Idec's Tecfidera to at least one of their multiple sclerosis (MS) patients, far surpassing the one-year trial rate for...

2014-06-12 08:29:46

-- Parion has a plan for the first clinical trial in patients with dry eye disease to initiate in July 2014 DURHAM, N.C., June 12, 2014 /PRNewswire/ -- Parion Sciences, Inc. (Parion) announced today that Parion and Santen Pharmaceutical Co., Ltd. (Santen) have entered into the "OPTION, LICENSE AND DEVELOPMENT AGREEMENT", an exclusive option agreement for the development and commercialization of P-321 for dry eye disease in certain Asian territories. On May 1, 2014 Parion announced...

2014-06-12 08:29:14

RALEIGH, N.C., June 12, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the treatment and diagnosis of metabolic disease, announced today it will present three peer-reviewed posters relating to its differentiated sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate, at the 74(th) American Diabetes Association (ADA) Scientific Sessions at the Moscone Center in San Francisco, June 13-17. Two of...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related